Key facts
- Njord Medtech’s last known valuation is $6.6M (Dec 2024).
- It has raised $3.6M; the latest was Later Stage VC ($1.4M) in Dec 2024.
- Notable investors include Almi Invest, GOBIA Enterprises, IDA InWest, Klint Ventures, Life Science Invest — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Njord Medtech
- ·The full record, as it builds
Funding rounds
No funding rounds for Njord Medtech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Njord Medtech
Developer of medical devices designed to provide patient-centric healthcare. The company offers a motorized lateral patient transfer device for horizontal patient movement and turning of bedridden patients without the need for manual lifting, enabling specialist care departments to improve the work environment and productivity.
- Sector
- Healthcare
- HQ
- Gothenburg, Sweden
- Founded
- 2019
- Employees
- 10
- Website
- njordmedtech.com/
- Ownership
- Privately Held (backing)
Njord Medtech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Njord Medtech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Njord Medtech in its N-PORT filings yet. We sweep new filings monthly.